Hypercell Technologies has developed novel biological solutions to control infectious diseases in production animals that cause major economic losses and present potential threats to human health. The Hypercell approach revolutionizes the control of infectious diseases by bringing two innovative technologies: rapid, easy-to-use molecular diagnostics on the farm and biotherapeutic treatments to reduce the spread of a virus. Hypercell believes the best chance to stop a future pandemic in humans is to proactively control viruses in animal reservoirs.
EnterpriseWorks Tenure: 2021 – 2024